Raymond James & Associates’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,308
Closed -$103K 3756
2023
Q2
$103K Buy
+12,308
New +$103K ﹤0.01% 3581